Bruna Maria de Sá Pereira

Bruna Maria de Sá Pereira

Auto-generated profile, based on publicly available information

Bruna Maria de Sá Pereira

Clinical Research Department, National Cancer Institute (INCA), Rio de Janeiro 20231-091, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
JGJoão Victor da Silva Guerra
João Victor da Silva Guerra
BPBruna Maria de Sá Pereira
Bruna Maria de Sá Pereira
JCJéssica Cruz
Jéssica Cruz
NSNicole Scherer
Nicole Scherer
CFCarolina Furtado
Carolina Furtado
Mariana MaschiettoMariana Maschietto
Mariana Maschietto
To identify underlying mechanisms involved with metastasis formation in Wilms tumors (WTs), we performed comprehensive DNA methylation and gene expression analyses of matched normal kidney (NK), WT blastemal component, and metastatic tissues (MT) from patients treated under SIOP 2001 protocol. A linear Bayesian framework model identified 497 differentially methylated positions (DMPs) between groups that discriminated NK from WT, but MT samples were divided in two groups. Accordingly, methylation variance grouped NK and three MT samples tightly together and all WT with four MT samples that showed high variability. WT were hypomethylated compared to NK, and MT had a hypermethylated pattern compared to both groups. The methylation patterns were in agreement with methylases and demethylases expression. Methylation data pointed to the existence of two groups of metastases. While hierarchical clustering analysis based on the expression of all 2569 differentially expressed genes (DEGs) discriminated WT and MT from all NK samples, the hierarchical clustering based on the expression of 44 genes with a differentially methylated region (DMR) located in their promoter region revealed two groups: one containing all NKs and three MTs and one containing all WT and four MTs. Methylation changes might be controlling expression of genes associated with WT progression. The 44 genes are candidates to be further explored as a signature for metastasis formation in WT.

1 December 2019 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
BPBruna M de Sá Pereira
Bruna M de Sá Pereira
RMRafaela Montalvão
Rafaela Montalvão
JNJoaquim Caetano de Aguirre Neto
Joaquim Caetano de Aguirre Neto
CMClarice Franco Menezes
Clarice Franco Menezes
KRKarla Emília Rodrigues
Karla Emília Rodrigues
Mariana MaschiettoMariana Maschietto
Mariana Maschietto
SUMMARY Childhood renal tumors account for ~7% of all childhood cancers, and most cases are embryonic Wilms’ tumors (WT). Children with WT are usually treated by either COG or SIOP. The later treats the children using preoperative chemotherapy, but both have around 90% of overall survival in five years. WT is a genetically heterogeneous group with a low prevalence of known somatic alterations. Only around 30% of the cases present mutation in known genes, and there is a relatively high degree of intra-tumor genetic heterogeneity (ITGH). Besides potentially having an impact on the clinical outcome of patients, ITGH may interfere with the search for molecular markers that are prospectively being tested by COG and SIOP. In this review, we present the proposal of the current UMBRELLA SIOP Study 2017/Brazilian Renal Tumor Group that requires the multi-sampling collection of each tumor to better evaluate possible molecular markers, as well as to understand WT biology

10 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
LTLjubica Tasic
Ljubica Tasic
NANataša Avramović
Nataša Avramović
MQMelissa Quintero
Melissa Quintero
DSDanijela Stanisic
Danijela Stanisic
LMLUCAS GELAIN MARTINS
LUCAS GELAIN MARTINS
Mariana MaschiettoMariana Maschietto
Mariana Maschietto
Pediatric cancer NMR-metabonomics might be a powerful tool to discover modified biochemical pathways in tumor development, improve cancer diagnosis, and, consequently, treatment. Wilms tumor (WT) is the most common kidney tumor in young children whose genetic and epigenetic abnormalities lead to cell metabolism alterations, but, so far, investigation of metabolic pathways in WT is scarce. We aimed to explore the high-resolution magic-angle spinning nuclear magnetic resonance (HR-MAS NMR) metabonomics of WT and normal kidney (NK) samples. For this study, 14 WT and 7 NK tissue samples were obtained from the same patients and analyzed. One-dimensional and two-dimensional HR-MAS NMR spectra were processed, and the one-dimensional NMR data were analyzed using chemometrics. Chemometrics enabled us to elucidate the most significant differences between the tumor and normal tissues and to discover intrinsic metabolite alterations in WT. The metabolic differences in WT tissues were revealed by a validated PLS-DA applied on HR-MAS T2-edited 1H-NMR and were assigned to 16 metabolites, such as lipids, glucose, and branched-chain amino acids (BCAAs), among others. The WT compared to NK samples showed 13 metabolites with increased concentrations and 3 metabolites with decreased concentrations. The relative BCAA concentrations were decreased in the WT while lipids, lactate, and glutamine/glutamate showed increased levels. Sixteen tissue metabolites distinguish the analyzed WT samples and point to altered glycolysis, glutaminolysis, TCA cycle, and lipid and BCAA metabolism in WT. Significant variation in the concentrations of metabolites, such as glutamine/glutamate, lipids, lactate, and BCAAs, was observed in WT and opened up a perspective for their further study and clinical validation.

5 May 2021 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
BPBruna Maria de Sá Pereira
Bruna Maria de Sá Pereira
RMRafaela Montalvão
Rafaela Montalvão
JGJoão Victor da Silva Guerra
João Victor da Silva Guerra
PFPaulo A. Faria
Paulo A. Faria
SLSheila Lima
Sheila Lima
Mariana MaschiettoMariana Maschietto
Mariana Maschietto